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Abstract
Spontaneous leaflet fracture of mechanical heart valve prostheses is very rare. We
describe a case of spontaneous leaflet embolization 31 years after aortic valve
replacement with an Edwards-Duromedics prosthesis (Baxter Healthcare Corp.,
Edwards Division, Santa Ana, CA). We review the literature on this subject to increase
awareness and recognition for this potentially life-threatening complication.
K E YWORD S
aortic valve replacement, Bjork Shiley, HFPF, cavitation, Edwards Duromedics, emergency
surgery, leaflet escape, valve failure
1 | INTRODUCTION
Spontaneous leaflet fracture of mechanical heart valve prostheses
is very rare. It is potentially life threatening and usually requires
emergent surgery. There are a few valve prosthesis series well-
known for having a higher risk of such mechanical structural valve
failure, of which the Björk-Shiley convexoconcave (BSCC) mono-
strut tilting disc prosthetic aortic heart valve (Pfizer, Rye Brook,
NY) is the most documented.1 Fractures of the BSCC valve's outlet
struts and subsequent escape of the disc was estimated at 0.7% for
all BSCC valves, but was up to 3.9% for the 70° opening angle
model, often leading to massive regurgitation and death.1
Unfortunately, besides the BSCC valve, there are other mechani-
cal heart valve prosthesis brands that have an increased risk of
mechanical structural valve failure. We report a case of spontaneous
leaflet fracture and escape 31 years after aortic valve replacementwith
an Edwards-Duromedics (ED) bileaflet mechanical prosthesis (Baxter
Healthcare Corp., Edwards Division, Santa Ana, CA) in a 63-year-old
male who developed life-threatening acute aortic regurgitation in
whom emergent surgical treatment was necessary. To the best of our
knowledge, this case presents the longest period between prosthesis
implantation and leaflet escape. In addition, a review of the available
literature on this subject is presented.
2 | PATIENT PROFILE
A 63-year-old male presented to a local hospital with cardiogenic
shock. His previous medical history included endocarditis 31 years
ago for which he underwent antibiotic treatment and aortic valve
replacement with a 27-mm ED bileaflet mechanical prosthesis. A
computed tomography (CT) of thorax and abdomen showed a
saccular aneurysm of the ascending aorta measuring 83 × 47mm (at
the level of the previous aortotomy), and changes consistent with
pulmonary edema. Coronary angiography (CAG) demonstrated no
coronary abnormalities; however, it confirmed severe aortic
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regurgitation and the absence of one leaflet of the mechanic aortic
valve prosthesis (Figure 1A). Subsequent echocardiography con-
firmed a severe aortic regurgitation with preserved left ventricular
function (Figure 1B). The patient was intubated and transferred to
our center for emergent operative therapy.
During induction of anesthesia, the patient went into cardiac
arrest and emergent surgery was performed and cardiopulmonary
bypass (CPB) was initiated with cannulation of the left femoral artery
and vein. Amediansternotomywas performed and the distal ascending
aorta was crossclamped and the heart arrested with cold antegrade
Custodiol cardioplegia (Dr. Franz Köhler Chemie GmbH, Bensheim,
Germany). Inspection of the mechanical aortic valve prosthesis
confirmed a missing prosthetic leaflet (Figure 2), without signs of
pannus, paravalvular leakage, or thrombus formation. The valve
prosthesis and diseased ascending aorta and aortic root were excised
and replaced with a 2-mm Perimount Magna Ease biological aortic
valve (Edwards Lifesciences®, Irvine, CA) and a vascular graft
(Vascutek® Gelweave prosthesis Æ 32mm, Terumo Cardiovascular
Group, Ann Arbor, MI), with reimplantation of the coronary ostia. The
patient was weaned fromCPB and the arterial and venous canula were
removed. Duration of aortic crossclamping was 93min and total CPB
time was 178min. A 3D reconstruction of the previously made CT
revealed the missing leaflet to be located in the left superficial femoral
artery (Figures 3A and 3B). After decannulation, the left femoral artery
was explored and two-thirds of the leaflet were found and removed
(Figure 3C). Postoperative, an additional CT scan located the other
one-third of the leaflet in the left popliteal artery. Removal was not
indicated due to the non-occlusive position of the leaflet and normal
ankle-brachial pressure index of 1,1. After discharge the patient
received warfarin to prevent thrombotic complications of the
remaining leaflet fragment. The patient made an uneventful recovery
and remains asymptomatic one year following surgery.
3 | INCIDENCE AND OUTCOMES
FOLLOWING MECHANICAL VALVE STRUT
FRACTURES
As mentioned earlier, the BSCC valve is the most well-known
example of mechanical structural heart valve failure, associated
with more known serious adverse outcomes than any other
implanted medical device.1 Following its introduction in 1979, by
2003 >600 cases were known to have valve fractures, often
leading to sudden cardiac deaths.1 In addition to the BSCC valve,
there are other valves that carry a higher risk for leaflet fracture
and subsequent leaflet escape, of which the most prominent is the
ED prosthesis (as illustrated by our case), followed by the TRI
Technologies (TRI Technologies Prosthetic Heart Valve, Ltda, Belo
Horizonte, Brazil) mechanical valve.2–8
The ED prosthesis (Baxter Healthcare Corp., Edwards Division)
is a bileaflet mechanical heart valve first introduced and implanted in
1982. After approximately 20,000 valve prostheses were implanted
the valve was withdrawn from the market in 1988 after at least 46
cases of leaflet escape were registered by the manufacturer.9 The
original valve was modified to correct structural problems and was
reintroduced in 1990 as the Edwards TEKNA bileaflet valve.
However, despite the revisions to the valve, cases of leaflet escape
continued which led to the discontinuation of the TEKNA valve in
2000.
Twenty-one papers reporting 23 cases involving ED or Edwards
TEKNA valves were published after discontinuation9–28 (Table 1). In
these cases, fractured leaflets occured more commonly from
mechanical mitral valves compared to aortic valves (87% vs 13%).
This is attributed to differences in dynamics and pressures over the
mitral valve compared to protheses in the aortic position.29 Duration
between prosthesis implantation and leaflet escape varies among
cases. The mean period from initial surgery until leaflet escape is
9.1 ± 7.4 years for mitral valves (n = 19) and 4.5 ± 3.1 years for aortic
valves (n = 3, P = 0.908). Our current case, which is 31 years between
initial surgery and leaflet escape, is the longest period between valve
implantation and the event. Patients tend to present with acute severe
dyspnea due to fulminant pulmonary edema and left-sided cardiac
dysfunction. All patients underwent emergency surgery. Four patients
did not survive acute cardiac decompensation or emergency surgery,
and the mortality rate is estimated at 17% among published cases
(Table 2).
Leaflet escape in mechanical heart valves of other manufactures
is very rare and is limited to single case reports, including an
Omnicarbon aortic valve prosthesis30 (Medical Inc., Inver Grove
FIGURE 1 Angiography (A) and trans-thoracic echocardiography (B) showing missing leaflet and aortic regurgitation
VAN STEENBERGEN ET AL.2 |126
FIGURE 2 Mechanic aortic valve with missing leaflet in anatomic position (A) and after removal (B)
FIGURE 3 Localization of missing leaflet on computed tomography (A and B). Two-third of the leaflet was recovered (C) from the deep
femoral arteries
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Heights, MN), a St. Jude mitral valve prosthesis31 (St. Jude Medical,
St. Paul, MN), and an On-X mitral valve prosthesis32 (Medical Carbon
Research Institute, Austin, TX). Similar to the ED valve, patients
present with cardiac failure and emergency surgery was performed
in all cases (Table 3).
4 | DIAGNOSIS OF LEAFLET FRACTURE
AND ESCAPE
Transthoracic echocardiography is used to diagnose a missing
leaflet.14,26,27 Transthoracic echocardiography in our case showed
major aortic regurgitation but did not clearly identify the missing
leaflet. We diagnosed the missing aortic valve leaflet using
fluoroscopy while performing CAG. The radio-opacity of the carbon
that is used to design mechanic heart valves makes it very easy to
observe the absence of simultaneous movement of leaflets or a
stenotic valve by leaflet immobility (Figure 2). Fluoroscopy could
therefore be a valuable alternative to trans-thoracic echocardiogra-
phy when imaging with echocardiography is difficult such in obese
patients.
Computer tomography is a reliable imaging technique to localize
escaped leaflets. In our review of the ED and/or Edwards TEKNA
valves, most leaflets migrated to the abdominal aorta (13%) or iliac
arteries (78%), and in one case to the brachiocephalic artery (Table 1).25
In 48% of cases a leaflet fracture was demonstrated (Table 1). Other
valve brands show similar locations for leaflet embolization (Table 3).
Our patient also had a fragmented leaflet, of which 2/3 of the leaflet
was located in left superficial femoral artery and 1/3 in the left
popliteal artery (Figure 3). In cases where the escaped leaflet is still
missing or fragmentation is suspected, we recommend to perform a
full-body CT, preferably with 3D reconstruction.
TABLE 1 Published cases on Edwards-Duromedics (E-D) leaflet escape
(First) author, year of
publication
Patient
count
Type of
E-D Position
Duration to escape
in years
Cardiogenic
shock
Emergency
surgery Alive
Fragmentized
leaflet
Location of
leaflet
Deuvaert et al.10 1 Original Mitral NR + + - − AA
Klepetko et al.11 2 3 Original Mitral
Mitral
3.16 3 NR + + + − − IFA
Kumar et al.12 4 5 Original Mitral
Mitral
5 2 + + + + − − IFA
Baumgartner et al.13 6 Original Mitral 2 + + + + IFA
Podesser et al.14 7 Original Mitral 8 NR NR − − LVOT
Hemmer et al.15 8 9 Original
Tekna
Mitral
Mitral
14 3 + + + + + + − + AA, IFA
Mastroroberto et al.9 10 Original Mitral 12 + NR − NR NR
Sudo et al.16 11 Original Mitral 10 + + + + IFA
Christiansen et al.17 12 Tekna Aortic 3.5 + + + + IFA
Jazayeri et al.18 13 Tekna Mitral 5 NR + + + AA, IFA
L’Huillier et al.19 14 Tekna Mitral 5 + + + − AA
Tatou et al.20 15 Original Mitral 6 + + + + IFA
Youn and Yoo21 16 Original Mitral 6 + + + − AA
Mert et al.22 17 Revised Mitral 7.16 NR + + + IFA
Pfeiffer et al.23 18 Tekna Aortic 8 + − − + IFA
Fragoulis and
Palatianos24
19 Tekna Mitral 12 + + NR + IFA
Yamazaki et al.25 20 Original Mitral 17 + + + + BCA, IFA
Collison and Mishra26 21 Tekna Aortic 2 + + + − IFA
Kim et al.27 22 Original Mitral 27 + + + − IFA
Kobayashi et al.28 23 Original Mitral 26 + + + + IFA
Our case 24 Original Aortic 31 + + + + IFA
AA, abdominal aorta; BCA, brachiocephalic artery; IFA, Ileofemoral arteries; LVOT, left ventricular outflow tract; NR, not reported.
TABLE 2 Overview of published cases including our case of Edwards−Duromedics leaflet escape
Variable Overall (N = 24) Aortic valve (N = 4) Mitral valve (N = 20)
Lethality 17%
Period from initial surgery until leaflet escape (years ± SD) 9.5 ± 8.4 11.1 ± 13.5 9.1 ± 7.4*
In one case duration to escape was not reported. SD, standard deviation.
VAN STEENBERGEN ET AL.2 |128
5 | PATHOGENESIS AND RISK OF LEAFLET
FRACTURE AND ESCAPE
Valve failure is most often due to outlet strut fracture leading to
dislodgement and embolization of the occluder disc.1 Metallurgic
analyses have shown that these fractures are caused by a combination
of abnormal outlet strut loading (due to its bimodal closure pattern)
with inferior weld quality.33
Multiple factors have been hypothesized for the cause of
increased risk of leaflet fracture and escape in the Edwards-
Duromedics prostheses, including inadequate compliance of the
sewing ring (reducing shock absorption) and surgical mishandling
during prosthesis implantation.34 In addition, other potential causes for
accelerated material deterioration include assymetric valve closure
with local stresses, and clustered micro-porosity of the pyrolytic
carbon. Cavitation has been identified as the most contributing factor
to failure of the Edward-Duromedics prosthesis.34
Cavitation is the process in which pressure differences in blood
flow cause formation of unstable air bubbles that subsequently
collapse and thereby release energy, leading to pitting and micro-
cracking of the prosthesis.35 Studies have reported that the
cavitation threshold is much lower for Edwards Duromedics valves
when compared to other bileaflet prostheses, leading to earlier and
more severe damage.36 The collapse of bubbles (and thus cavitation)
produces a sound (high-frequency pressure fluctuations [HFPF]) that
can be quantified.37 In a 2004 review by Johansen et al, the
measurement of HFPF was proposed as a promising method to
detect cavitation in vivo, and might aid in the determination of valve
function and imminent failure. However, HFPF measurement has not
yet been validated to objectify or quantify cavitation in human
subjects, and other methods are not readily available. Much work
needs to be done to develop a non-invasive method to reliable
quantify HFPF with relation to the extent of cavitation, with the
purpose of identifying valve prostheses that are high-risk for
structural detoriation.
Investigation into cases with valves other than the ED valve
revealed significant tab malalignment and asymmetry in the TRI Tech
valves in which tab fracture and leaflet escape had occurred.3–5 Similar
to the ED valve, valve analysis of fractured leaflets showed cavitation
as the main contributing factor to valve failure and leaflet escape.3–5
6 | INDICATIONS FOR PROPHYLACTIC
REOPERATIVE VALVE REPLACEMENT?
In the BSCC cases a Dutch research group showed that the 70°
opening angle, large valve size, mitral position and young age were the
most important determinants for risk of outlet strut fracture (OSF).38
Furthermore, analysis of manufacturers data showed that several
aspects of the manufacturing process (eg, repetitive testing) also
increased the risk of outlet strut fractures.1 Based on these risk factors,
advisory algorithms were devised to aid cardiothoracic surgeons in
making a case-to-case decision on prophylactic BSCC replacement.38–
41 It was concluded that each case should be assessed individually for a
proper balance between surgical mortality and gain in life expectancy
after reoperation, against the risk of OSF and subsequent loss of life
expectancy. Fortunately, the majority of the BSCC patients are now
over 70 years of age and the annual incidence of OSF is estimated
between 0.02% and 0.04% annually.1
These indications for elective prophylactic reoperation can be
extrapolated to patients with ED or TRI Technologies valves. Each case
should be examined individually, and operative risk should be assessed
compared to the risk of leaflet escape. Some clinics have offered
prophylactic reoperations in asymptomatic patients to replace the TRI
Technologies valve with excellent results. In one series, operative
mortality was 0% in 22 patients and none of these patients
experienced permanent complications.4,5 Nevertheless, in contrast
TABLE 3 Published cases on mechanical heart valve leaflet escape (excluding cases involving Edwards−Duromedics and Bjork−Shiley
prostheses)
Valve type
(First) author, year
of publication
Patient
count Position
Duration to
escape in years
Cardiogenic
shock
Emergency
surgery Alive
Fragmentized
leaflet
Location
of leaflet
TRI−Technologies Bottio et al.2 1 Aortic 0.03 NR − − − AA
2 Mitral 1.66 NR + + − AA
Dikmengil et al.3 3 Mitral 0.33 + + − − AA
Gerosa et al.4 4 Aortic NR NR − − NR IFA
Cianciulli et al.5 5 Mitral 3 + + NR NR NR
Zhang et al.6 6 Mitral 3 + + + − AA
Barbera et al.7 7 Mitral NR NR + + NR NR
8 Aortic NR NR NR − NR NR
9 Aortic NR NR NR − NR NR
Omnicarbon Kornberg et al.30 12 Aortic 3.5 + + + + AA
St Jude Mosterd et al.31 10 Mitral 1.5 + + NR + IFA
On−X Kageyama et al.32 11 Mitral 5 + + − − AA
AA, abdominal aorta; IFA, Ileofemoral arteries; NR, not reported.
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to the large amount of data available for the BSCC cases, there is
unfortunately no literature available in which large cohorts are
analyzed and thoroughly examined for risk factors for leaflet fracture
and escape in patients with ED or TRI Technologies valves. The
incidence of BSCC leaflet fracture by far exceeds the amount of cases
published on ED leaflet escape and therefore results of multivariate or
survival analysis will not be statistically correct or interpretable in
current ED and TRI Technologies cohorts.
Future research should therefore explore patient- and prosthe-
sis-related factors that increase the risk of leaflet escape, performed
in large groups of patients in order to make a similar algorithm for ED
or TRI Technologies valve patients. Until then, routine replacement
of ED or TRI Technologies heart valves in asymptomatic patients
with good-functioning valves on echocardiography cannot be
recommended.
7 | CONCLUSIONS
Clinicians should be aware of the possibility of leaflet instability in
patients with prosthetic heart valves, especially with ED and Edwards
TEKNA valves. In these patients presenting with symptoms of sudden
acute decompensated heart failure or cardiogenic shock, valve
dysfunction should be strongly suspected, and we recommend
angiography or transthoracic echocardiography and emergency
surgery when leaflet escape is present. Further research for detection
of cavitations and risk factors that make asymptomatic patients prone
to leaflet escape in ED and Edwards TEKNA valves is needed to
identify possible high-risk cases for valve fractures and to develop
guidelines for prophylactic valve replacement.
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